ARVINAS

Trademark usage description

pharmaceutical preparations for use in treating oncology, immunology, and inflammatory diseases, and central nervous system disorders. pharmaceutical Read More

Classification Information

Class [005]
Pharmaceutical preparations for use in treating oncology, immunology, and inflammatory diseases, and central nervous system disorders.

Classification kind code

Class [042]
Pharmaceutical products development of new small molecules aimed at degrading disease-causing cellular proteins for treatment in the field of oncology, immunology, inflammatory diseases, and central nervous system disorders.

Classification kind code

Mark Details

Serial Number

2087875

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 8^th Oct 2024	Search Recorded
Submitted for opposition 20 on 8^th Oct 2024	Examiner's First Report
Submitted for opposition 287 on 29^th Jun 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 26^th Feb 2021	Filed
Submitted for opposition 1 on 26^th Feb 2021	Created
Submitted for opposition 31 on 26^th Feb 2021	Formalized

ARVINAS

Classification Information

Class [005]Pharmaceutical preparations for use in treating oncology, immunology, and inflammatory diseases, and central nervous system disorders.

Classification kind code

Class [042]Pharmaceutical products development of new small molecules aimed at degrading disease-causing cellular proteins for treatment in the field of oncology, immunology, inflammatory diseases, and central nervous system disorders.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceutical preparations for use in treating oncology, immunology, and inflammatory diseases, and central nervous system disorders.

Class [042]
Pharmaceutical products development of new small molecules aimed at degrading disease-causing cellular proteins for treatment in the field of oncology, immunology, inflammatory diseases, and central nervous system disorders.